A detailed history of Parkman Healthcare Partners LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 447,196 shares of BSX stock, worth $40.3 Million. This represents 5.29% of its overall portfolio holdings.

Number of Shares
447,196
Previous 551,592 18.93%
Holding current value
$40.3 Million
Previous $42.5 Million 11.78%
% of portfolio
5.29%
Previous 6.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $7.62 Million - $8.77 Million
-104,396 Reduced 18.93%
447,196 $37.5 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $8.49 Million - $9.8 Million
126,119 Added 29.64%
551,592 $42.5 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $13.1 Million - $15.6 Million
-227,330 Reduced 34.82%
425,473 $29.1 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $2.7 Million - $3.21 Million
55,543 Added 9.3%
652,803 $37.7 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $6.23 Million - $6.79 Million
124,155 Added 26.24%
597,260 $31.5 Million
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $2.23 Million - $2.45 Million
44,874 Added 10.48%
473,105 $25.6 Million
Q1 2023

May 12, 2023

BUY
$45.09 - $50.03 $2.72 Million - $3.02 Million
60,298 Added 16.39%
428,231 $21.4 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $796,975 - $951,294
20,146 Added 5.79%
367,933 $17 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $12.8 Million - $38.1 Million
347,787 New
347,787 $13.5 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $7.1 Million - $12.6 Million
-275,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$37.87 - $45.37 $10.4 Million - $12.5 Million
275,000 New
275,000 $12.4 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.